Citi Pharma Limited (KASE: CPHL)
Health Care · Pharmaceuticals · PK
PKRs72.86
-2.96% today · -17.6% 1Y
Citi Pharma Limited (KASE: CPHL) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $59.95M.
Over the last twelve months the share price has lost 17.6%, trading between 69.25 and 104.25.
Tweenvest scores Citi Pharma Limited across four factors: quality 63/100, value 57/100, growth 64/100, dividend 68/100. Its strongest factor is dividend.
CPHL price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $59.95M
- Revenue (TTM)
- $49.61M
- P/E
- 15.18
- EPS
- 4.80
- Dividend yield
- 4.80%
- Beta (5Y)
- 0.43
- 52-week high
- PKRs104.25
- 52-week low
- PKRs69.25
- Avg volume (3M)
- —
- Shares outstanding
- 228.46M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,244.69 | -0.18% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $270.70 | -0.86% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $151.00 | +0.23% |
| Roche Holding AGSWX: ROP | $368.80B | CHF370.90 | +0.13% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £121.72 | +0.51% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $27.98 | +0.04% |
Figures last refreshed Aug 18, 2026.